Evidence map›Paper›PMID 40921942›Full record

ArticleMikrochimica acta2025

Enhanced sensitivity detection via orientational labelling of SPA-functionalized magnetic nanoparticles in lateral-flow immunoassays.

Penghua Zhao, Yaping Li, Qing Feng, Xueping Huo, Jingying Sun, Zifan Lu, Zhangjun Song

Abstract read
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Penghua ZhaoResearch Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Yaping LiResearch Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Qing FengResearch Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Xueping HuoResearch Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Jingying SunResearch Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
Zifan LuResearch Centre of Cell Immunological Engineering and Technology of Shaanxi Province, Shaanxi Provincial People's Hospital, Xi'an, 710068, China. pharmluzifan@163.com.
Zhangjun SongDepartment of Surgical Oncology, Shaanxi Provincial People's Hospital, 256 Friendship West Road, Beilin District, Xi'an, 710068, Shaanxi, China. DoctorSong051107@126.com.

Funding

Key Research and Development Program of Shaanxi Province 2024SF-YBXM-081Shaanxi Provincial People's Hospital Science and Technology Development Incubation Fund 2023YJY-22
6 · The paper itself

Abstract

Mycoplasma pneumonia, a primary aetiological agent of atypical pneumonia, necessitates the implementation of rapid point-of-care diagnostics. Lateral flow immunoassays (LFIAs) hold promise for point-of-care testing (POCT), yet their sensitivity levels are frequently constrained by probe affinity and matrix interference. We introduce an orientational labelling strategy that employs magnetic nanoparticles (MNPs) functionalized with staphylococcal protein A (SPA) to simultaneously enhance antibody orientation and facilitate magnetic enrichment. The SPA-MNPs were synthesized via aggregation‒precipitation crosslinking, utilizing the Fc-binding specificity of SPA to enable oriented antibody conjugation and reduce steric hindrance. The oriented probe demonstrated robust stability, exceptional specificity, and enhanced binding affinity, which were considered crucial for the detection of low-abundance targets. In concentration gradient tests, the orientational labelling method resulted in the lowest visible colorimetric signals at 10

Indexed as

Magnetite NanoparticlesStaphylococcal Protein AAntibodies, ImmobilizedHumansImmunoassayLimit of DetectionMycoplasma pneumoniaeAntibodies, ImmobilizedMagnetite NanoparticlesStaphylococcal Protein ACapture-binding kineticsLateral flow assayMagnetic enrichmentMycoplasma pneumoniaOrientational labellingSPA-functionalized magnetic nanoparticles

Identifiers

PMID40921942
PMCPMC12417246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.